Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERA-HF: Empagliflozin for Arrhythmic Events in Heart Failure
NCT03271879Phase 4Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Feb 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of empagliflozin in heart failure (HF), type 2 diabetes mellitus (T2DM), sponsored by Rambam Health Care Campus. Status: unknown.
02
Drugs
empagliflozin
03
Conditions
heart failure (HF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03271879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03271879.